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Articular cartilageThe CCN family of proteins plays important roles in development and homeostasis of bone and cartilage. To un-
derstand the role of CCN4 in chondrogenesis, human bonemarrow stromal cells (hBMSCs)were transducedwith
CCN4 adenovirus (adCCN4) or siRNA to CCN4 (siCCN4) in the presence or absence of transforming growth factor-
β3 (TGF-β3). Overexpression of CCN4 enhanced TGF-β3-induced SMAD2/3 phosphorylation and chondrogenesis
of hBMSCs in an in vitro assay using amicromass culturemodel. On the other hand, knockdown of CCN4 inhibited
the TGF-β3-induced SMAD2/3 phosphorylation and synthesis of cartilage matrix in micromass cultures of
hBMSCs. Immunoprecipitation–western blot analysis revealed that CCN4 bound to TGF-β3 and regulated the
ability of TGF-β3 to bind to hBMSCs. In vivo analysis conﬁrmed there was a signiﬁcant decrease in the gene ex-
pression levels of chondrocyte markers in cartilage samples from Ccn4-knock out (KO) mice, compared to
those from wild type (WT) control. In order to investigate the regenerative properties of the articular cartilage
in Ccn4-KO mice, articular cartilage defects were surgically performed in the knee joints of young mice, and
the results showed that the cartilage was partially repaired in WTmice, but not in Ccn4-KO mice. In conclusion,
these results show, for the ﬁrst time, that CCN4 has a positive inﬂuence on chondrogenic differentiation bymod-
ulating the effects of TGF-β3.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
Osteoarthritis (OA), which is characterized by the degeneration and
loss of articular cartilage and subchondral bone, is one of themost com-
mon disorders of the musculoskeletal system, and is caused mainly by
the effects of aging, trauma or injury and overloading, such as in the
case of obesity. The main symptoms of OA of the hip or knee are pain
and stiffness, causing loss of joint mobility. Articular cartilage consists
basically of a single cell type, the chondrocyte, which can synthesize
all components of the extracellular matrix (ECM), and the mechanical
function and properties of articular cartilage is greatly dependent on
the quality and quantity of ECM. However, adult cartilage has a poor ca-
pacity for repair and regeneration. Therefore, autologous chondrocyte
transplantation has beenwidely used. Stemcell therapy,which employs
the use of stem/progenitor cells from different tissue or induced-habilitation and Regenerative
of Medicine, Dentistry and
ayama-shi, Okayama-ken 700-
o).pluripotent stem cells (iPSCs), has gained particular attention in recent
years. However, a deeper understanding of the detailed mechanisms of
chondrogenic differentiation of stem/progenitor cells, including the in-
teraction with growth factors, is necessary to eventually improve the
current clinical outcomes for cartilage regeneration.
Transforming growth factor-beta (TGF-β) is a member of a family of
dimeric polypeptide growth factors and is classiﬁed into fourmajor sub-
families, TGF-βs, bone morphogenetic proteins (BMPs), activins/in-
hibins, and glia cell line-derived neurotrophic factors (GDNFs). Among
the TGF-β superfamily, TGF-β1, β2 and β3 are known to play important
roles not only in chondrocyte proliferation and differentiation but
also in embryonic development of cartilage through activation of
the SMAD2/3 signaling pathway; and alterations in TGF-β signaling
are known to be involved in the pathogenesis of OA and osteoporosis
[1,2]. In early stages of chondrogenesis from mesenchymal stem cell
condensation to limb bud formation, TGF-β activates SMAD3, which
binds to co-SMAD4, translocates to the nucleus and promotes the ex-
pression of Sox9, the master regulator of chondrogenesis [3].
The CCN family consists of six members, CCN1/Cyr61/Cef10, CCN2/
CTGF/Fisp12, CCN3/Nov, CCN4/WISP-1/rCOP-1/Elm-1, CCN5/WISP-2,
and CCN6/WISP-3. CCN family proteins are characterized by four
163Y. Yoshioka et al. / Bone 83 (2016) 162–170distinct functional domains: an insulin-like growth factor binding
protein like module (IGFBP), a von Willebrand factor type C repeat
(VWC), a thrombospondin type 1 repeat (TSP1), and a cysteine-rich C-
terminal module (CT). Because CCN family proteins have this unique
modular structure, they can interact with various other proteins, cell
membrane receptors and ECM components, and can regulate several
cell functions, including adhesion,migration, proliferation, and differen-
tiation both in vitro and in vivo. Interestingly, CCN family members can
interact with and regulate the activity of members of the TGF-β super-
family and orchestrate tissue development during osteogenesis and
chondrogenesis [4,5]. For instance, CCN2 was shown to promote the
proliferation and differentiation of chondrocytes by interacting with
BMP-2, FGF-2, and IGF-1 [4,6]. Additionally, our research group showed
that CCN4 regulates osteoblast function by controlling the activity of
TGF-β1 and BMP-2 [7,8].
Clinical and experimental evidence also suggest that CCN4 plays a
role in OA [9,10]. Previous studies reported a high expression of CCN4
in the synovium and cartilage in an experimental OA model in mice as
well as in human OA patients [10,11]. These ﬁndings suggest that
CCN4 may be involved in the chondrocyte differentiation and/or carti-
lage regeneration. However, the speciﬁc function of CCN4 in chondro-
genesis and cartilage regeneration remains unclear.
To understand the role of CCN4 in chondrogenesis, we investigated
the effect of CCN4 on the chondrogenic differentiation of human bone
marrow stromal cells (hBMSCs) using gain and loss of function models,
and found that CCN4 is a positive regulator of TGF-β3-induced
chondrogenic differentiation of hBMSCs in vitro. Moreover, in an exper-
imental animal model of full-thickness articular cartilage defect using
Ccn4-knock out (KO)mice, we showed that CCN4 is important for carti-
lage repair in vivo.
2. Materials and methods
2.1. Cells and culture medium
Human bone marrow stromal cells (hBMSCs) were purchased from
Lonza (Walkersville, MD, USA). Cells were cultured in α-MEM contain-
ing 10% fetal bovine serum (FBS), 1% L-glutamine (Life Technologies,
Rockville, MD, USA), and 1% penicillin and streptomycin (Sigma, St.
Louis, MO, USA) [Basal medium].
For chondrogenic differentiation, hBMSCs at passages 4 to 5
were used for analysis of chondrogenic differentiation. hBMSCs
were suspended (2 × 105 cells/10 μL) and cultured in micromasses, as
previously reported [12,13]. Chondrogenic medium consisted of
DMEM low glucose, supplemented with 6 μg/mL each of insulin, trans-
ferrin and selenous acid (ITS solution, BD, Bedford, MA, USA), 50 μg/mL
of L-Ascorbic Acid Phosphate Magnesium Salt n-Hydrate (Wako Pure
Chemical Industries, Osaka, Japan), 100 nM dexamethasone (Sigma),
10 ng/mL of rhTGF-β3 (R&D Systems, Inc., Minneapolis, MN, USA) and
antibiotics. Mediumwas changed every 3–4 days and sampleswere cul-
tured for 28 days prior to analysis.
For the overexpression of the CCN4 gene, hBMSCs were transfected
with adenovirus that express human CCN4 (adCCN4) as reported previ-
ously [8]. Adenovirus CMV empty vector (adCMV) was used as the neg-
ative control. For the knockdownof Ccn4 gene, hBMSCswere cultured in
penicillin and streptomycin-free basal medium, following the
manufacturer's instruction. Twenty four hours later, the medium was
changed to Opti-MEM Reduced-Serum Medium (Life Technologies)
supplemented with Lipofectamine RNAiMAX (Life Technologies) and
10 nM SiRNA to decrease the expression of human CCN4 (SiCCN4; Life
Technologies) according to the manufacturer's instructions. Stelth™
RNAi Negative Control High GC Duplex (Life Technologies) was used
as the negative control.
For the isolation of chondrocytes, the growth plates of femur, which
were collected from newborn WT and Ccn4-KO, were incubated with
Trypsin-EDTA (Life Technologies) for 30 min and 86.5 U/mL of Type 1collagenase (Worthington Biochemical Corporation, Lakewood, NJ,
USA) overnight at 37 °C. Isolated chondrocytes were cultured with
DMEM/F12 (Life Technologies) containing 10% fetal bovine serum
(FBS), 1% L-glutamine, and 1% penicillin and streptomycin.
2.2. Reverse transcription and real time RT-PCR analysis
Total cellular RNAwas extracted by RNAMinikit (Life Technologies),
according to themanufacturer's instructions. Possible residual DNAwas
removed by DNase (Purelink™DNase; Life Technologies). RNA samples
were reverse-transcribed by using iScript cDNA synthesis kit (Bio-Rad;
Hercules, CA, USA). Real time RT-PCRwas performed to quantify the ex-
pression of the target gene by using KAPA SYBR FAST qPCR Master Mix
(KAPA BIOSYSTEMS,Wilmington,MA, USA) and Chromo4 real-time de-
tector. The levels of mRNAs of interest were normalized to that of the
reference gene S29. Primer sequences are shown in Table 1.
2.3. Western blot analysis
Cells were lysed byM-PER (Mammalian Protein Extraction Reagent;
Thermo, Waltham, Massachusetts, USA) supplemented with a Protease
Inhibitor Cocktail (1mg/mL; Roche, Indianapolis, IN, USA) and Phospha-
tase Inhibitor Signal-Use Cocktail (1:100; Thermo). Cell debris were re-
moved from lysates by centrifugation at 12,000 rpm for 10 min at 4 °C.
Protein concentration in the cell lysate was determined by using
PierceⓇ BCA Protein assay kit (Thermo). Ten micrograms of the total
protein lysate was separated in precast polyacrylamide gels (NuPage,
Life Technologies) by electrophoresis and then transferred onto
polyvinylidene ﬂuoridemembranes (PVDF; GE Healthcare Life sciences,
Buckinghamshire, UK) at 30 V for 2 h. Blots were blocked and incubated
in primary antibodies to SOX-9 (1:1000; Millipore, Billerica, MA, USA),
phosphorylated SMAD2/3 (pSMAD2/3), total SMAD2/3 (1:1000; Cell
Signaling Technologies, Danvers, MA, USA) and β-ACTIN as a loading
control (1:5000; Sigma). Membranes were then washed, and incubated
inHRP-labeled anti-rabbit IgG (1:2000; Santa Cruz Biotechnology, Santa
Cruz, CA, USA) for 1 h at room temperature (RT). The blots were devel-
oped using Forte western HRP Substrate (Millipore), and visualized
with Image Quant LAS 4000 mini (Fujiﬁlm, Tokyo, Japan).
2.4. Immunoprecipitation
Cells were harvested using NP-40 buffer (1% NP-40, 0.15 M NaCl,
0.01 M sodium phosphate, and 1 mM ethylenediaminetetraacetic acid
(EDTA)) containing a Complete Protease InhibitorMixture (RocheDiag-
nostics, Mannheim, Germany). Cleared cell lysates were incubatedwith
magnetic beads conjugatedwith 4C5 anti-DDKmousemonoclonal anti-
body (OriGene, Rockville, MD, USA), or 1 μg mouse IgG1 kappa mono-
clonal [MOPC-21] isotype control (Abcam, Cambridge, UK) that was
previously bound to Dynabeads protein G (Life Technologies). The
beads were washed extensively, and the bound proteins were boiled
in loading buffer for 10 min at 70 °C and then separated by SDS-PAGE
and analyzed by immunoblot with 4C5 anti-DDK monoclonal antibody
(OriGene) or anti-CCN4 antibody (LF-187). Details on the construction
and speciﬁcity of LF-187 have been described previously [14,15].
2.5. Cell protein binding assay
To assess the effect of CCN4 on the cell binding afﬁnity of rhTGF-β3,
hBMSCs were seeded at a concentration of 1 × 104 cells/well in 96-well
plates. After 24 h, cellswere transfectedwith adCCN4 or siCCN4 for 48h.
Next, cells were ﬁxed for 15min at RTwith 4% paraformaldehyde (PFA),
washed and pre-blocked in 5% goat serum (Invitrogen) and 0.05% bo-
vine serum albumin (BSA) for 1 h at 37 °C. Cells were incubated with
30 ng/mL of TGF-β3 for 4 h at RT. Bound TGF-β3 ligands were detected
by incubating the cells with anti-TGF-β3 antibody (1:100; ProteinTech
Group, Inc., Chicago, IL, USA) overnight at 4 °C. Cells were washed and
Table 1
Primers used for Real time RT-PCR analysis.
Gene Species GenBank accession no. Primer sequence PCR product length (bp)
S29 Human BC032813 5′-T CTCGCT CTT GTCGT GT CT GTTC-3′(S)
5′-ACACTGGCGGCACATATTGAGG-3′(AS)
75
CCN1 Human AF003114 5′-GCCAATGAAGCAGCGTTTCCC-3′(S) 5′-CAAT
GAGT CCCAT CACCCACACC-3′(AS)
171
CCN2 Human BT019794 5′-T GCGAGGAGT GGGTGTGTGAC-3′(S)
5′-TGGACCAGGCAGTTGGCTCTAATC-3′(AS)
125
CCN3 Human BC015028 5′-GAGCAGTGCCAATCTACAGCGAAG-3′(S)
5′-AGATGGAGAAGCAGGAAGGTCAGG-3′(AS)
138
CCN4 Human AB034725 5′-ACACTCATTAAGGCAGGGAAGAAG-3′(S)
5′-TCAGGACACTGGAAGGACACG-3′(AS)
185
CCN5 Human BC058074 5′-CACACCGAAGACCCACCTCCTG-3′(S)
5′-GCAGCAGCCACAGCCATCC-3′(AS)
151
CCN6 Human AY358350 5′-GGGTACAGGGCACTGGACCATTAG-3′(S)
5′-ACAGCATCCACAGCCATCTCTCAC-3′(AS)
167
COL2A1 Human BT007205 5′-TGGAGCAGCAAGAGCAAGGAGAAG-3′(S)
5′-CCGTGGACAGCAGGCGTAGG-3′(AS)
136
S29 Mouse NM_009093 5′-GGAGTCACCCACGGAAGTTCGG-3′(S)
5′-GGAAGCACTGGCGGCACATG-3′(AS)
108
Sox-9 Mouse NM_011448 5′-TCAGATGCAGTGAGGAGCAC-3′(S)
5′-CCAGCCACAGCAGTGAGTAA-3′(AS)
208
Acan Mouse L07049 5′-CCCGGTACCCTACAGAGACA-3′(S)
5′-ACAGTGACCCTGGAACTTGG-3′(AS)
215
Col2a1 Mouse BC082331 5′-GGGCAACAGCAGGTTCACATACAC-3′(S)
5′-TCAATAATGGGAAGGCGGGAGGTC-3′(AS)
120
Col10a1 Mouse NM_009925 5′-TTCTGCTGCTAATGTTCTTGA-3′(S)
5′-AATGCCTTGTTCTCCTCTTAC-3′(AS)
164
Bgn Mouse L20276 5′-ACCTGTCCCCTTCCATCTCT-3′(S)
5′-CCGTGTGTGTGTGTGTGTGT-3′(AS)
201
Dcn Mouse X53929 5′-CCAACATAACTGCGATCCCT-3′(S)
5′-TGTCCAAGTGGAGTTCCCTC-3′(AS)
214
S, sense; AS, antisense.
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technology) for 1 h at RT. The amount of bound TGF-β3was determined
by tetramethylbenzidine (TMB) colorimetric substrate (Cell Signaling)
after incubation for 10 min at RT. The reaction was terminated with an
equal volume of 2 N H2SO4, and the optical absorbance was measured
at 450 nm.
2.6. In vivo full-thickness articular cartilage defect model in Ccn4 knockout
(KO) mice
Mice deﬁcient in Ccn4 (Ccn4−/−) were generated using standard
homologous recombination and gene targeting as described before
[16]. Wild type (WT) and Ccn4-KO mice (C57BL/6) at 6 weeks of age
were utilized in the experiments, according to the guidelines for Animal
Care and Use at the NIDCR (ASP #13-700), NIH. Full-thickness articular
cartilage defects were created according to a previously published re-
port [17]. Brieﬂy, three femaleWT and Ccn4-KOmicewere anesthetized
with isoﬂurane (2–5% in O2) and the joint capsule of the knee was
opened, and the patella was dislocated laterally to expose the distal
articular surface of the femur. Then, full-thickness articular cartilage
defects of 400 μm diameter were created using 27 G needles, which
has a diameter of 400 μm, in order to make the same size defect. Pene-
tration to subchondral bone was conﬁrmed by bleeding from the carti-
lage defect site. Muscles and patella were replaced on their original
position and muscles and skin were sutured in separate layers. Four
weeks after the surgery, animals were euthanized for histological
analysis.
2.7. Isolation of articular cartilage fromWT and Ccn4-KO mice
To compare the gene expression level of chondrocytemarkers in the
articular cartilage of WT and Ccn4-KO mice at 6 weeks of age, articular
cartilage samples were carefully collected from the caput femur of WTand Ccn4-KO mice under a surgical microscope. Total RNA was isolated
from the tissue samples using Trizol (Life Technologies), and gene ex-
pression levels of Sox9, aggrecan (Acan) and collagen type II, alpha 1
(Col2a1) were analyzed by real time RT-PCR.
2.8. Histological analysis and qualitative scoring
hBMSC pellets and mice samples were ﬁxed in 4% PFA, dehydrated
and embedded in parafﬁn. Serial sections of 5 μmweremade, hydrated,
and subsequently stained with hematoxylin and eosin (H&E), toluidine
blue or safranin O for staining of glycosaminoglycans, as described pre-
viously [12]. For immunohistochemical staining of collagen type II, par-
afﬁn sections were deparafﬁnized, rehydrated, antigen-retrieved,
blocked with 10% normal goat serum (Life Technologies) for 10 min,
and incubated overnight at 4 °C with anti-collagen type II antibody
(1:200; Millipore). Sections were then washed, incubated with second-
ary antibody and detected with 3-Amino-9-ethylcarbazole (AEC) color
developing reagent (SuperPicture™ HRP Polymer Conjugate Broad
Spectrum, Life Technologies), according to the manufacturer's instruc-
tions. In a blinded fashion, an examiner used a modiﬁed ICRS score to
evaluate the histological condition of the articular cartilage surface
post-surgery, as reported previously [12]. In pellet culture experiments,
quantitation of the positive area of collagen type II was performed using
a BZ-X700 microscope equipped with a BZ analyzer (Keyence, Osaka,
Japan).
2.9. Statistical analysis
The results obtained from quantitative experiments were reported
as the mean values ± SD. Statistical differences were examined using
a one-way factorial ANOVA followed by Tukey's multiple comparison
tests or Student's unpaired t-tests.
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3.1. Expression of CCN family members in hBMSC cultures during
chondrogenic differentiation in vitro
To obtain a better insight into themolecularmechanisms underlying
the role of CCN familymembers in the process of chondrogenic differen-
tiation of hBMSCs, we ﬁrst investigated the expression levels of mRNA
encoding genes of CCN family members in 21-day hBMSC micromass
cultures. Although the transcript levels of CCN5 and CCN6 ﬂuctuated
during the culture period, there was a relatively high increase in the
gene expression levels of CCN1, CCN2, CCN3 and CCN4 after the day 7,
which followed a similar expression pattern of COL2A1, suggesting
that these proteins could be playing important roles in modulating
chondrogenesis (Fig. 1).
3.2. CCN4 regulates TGF-β3-induced chondrogenesis of hBMSCs
Since CCN1, CCN3 andmainly CCN2 had already been reported to be
important factors regulating chondrocyte differentiation [3,18,19], we
evaluated the inﬂuenceof CCN4on the chondrogenic process of hBMSCs
by inducing CCN4 over-expression using adenovirus encoding CCN4
(adCCN4) as well as by silencing CCN4 gene using siCCN4. AdCCN4
was transduced into hBMSCs [8], and the increase in CCN4 gene expres-
sion level was conﬁrmed by real time RT-PCR, in comparison with
adCMV-transduced cells (Fig. 2A). Conversely, CCN4 gene expression
level was decreased with a targeted gene knock down using siCCN4
(Fig. 2E). First, we conﬁrmed that overexpression and down regulation
of CCN4 did not affect hBMSC proliferation by MTS assay (data not
shown). Next, since CCN4 is considered to be a downstream target ofFig. 1. Expression pattern of CCN family genes during chondrogenesis. hBMSCs were cultured i
RNAwas collected at 1, 3, 7, 14, and 21 days, and themRNA expression levels of CCN1 to CCN6 (A
normalized to that of S29 ribosomal RNA. Data are reported asmean±SD (n=3). *p b 0.05, **p
of at least three independent experiments.TGF-β [7], we tested the effect of CCN4 over expression and down regu-
lation on TGF-β3-induced chondrogenic differentiation of hBMSCs in a
micromass culture system. After 24 h of culture, we observed that
adCCN4-transduced cells presented a notable increase in SOX9 protein
levels (Fig 2B). In accordance, after 28 days of culture, we could observe
an intense staining with safranin O and Alcian blue for detection of gly-
cosaminoglycans, as well as an intense immunostaining for collagen
type II in adCCN4-transduced hBMSC cultures (Figs. 2C, S1). A quantita-
tive analysis of the major chondrocyte marker genes, ACAN and
COL2A1, conﬁrmed a marked increase in the levels of the two genes in
adCCN4-transduced hBMSC cultures, compared to adCMV (Fig. 2D). By
contrast, knockdown of CCN4 suppressed chondrogenic differentiation
of hBMSCs, as demonstrated by a decrease in SOX9 levels in 24 h
hBMSC pellets (Fig. 2F). Additionally, chondrocyte-like cells were nearly
absent, and ACAN and COL2A1 transcript levels were also signiﬁcantly
down regulated in siCCN4-transduced hBMSC micromasses, after
28 days of culture (Figs. 2G, H, S1). Taken together, these results demon-
strate that CCN4 plays an important role in enhancing chondrogenic dif-
ferentiation of hBMSCs in vitro.
3.3. CCN4 enhances TGF-β3-induced phosphorylation of SMADs
Next, in order to investigate the mechanism of how CCN4 interacts
with TGF-β3 during chondrogenic differentiation of hBMSCs, we cul-
tured the cells in monolayer, and transduced the cells with adCCN4.
Forty eight hours after adCCN4 transduction, stimulation with rhTGF-
β3 (10 ng/mL) for 10 min signiﬁcantly increased the phosphorylation
of SMAD2 and SMAD3 as compared to adCMV or TGF-β3-treated control
cells (Fig. 3A). In contrast, as a response to the CCN4 knockdown, TGF-
β3-induced activation of SMAD2 and SMAD3 was repressed in hBMSCsn a micromass culture system in chondrogenic induction medium for up to 21 days. Total
–F) and COL2A1 (G)were evaluated by real time RT-PCR. The expression of each genewas
b 0.01, ***p b 0.001 versus day 1 (one-way ANOVA/Tukey). Results are representative data
Fig. 2. The effect of CCN4 on the chondrogenic differentiation of hBMSCs in vitro. hBMSCswere transducedwith adCCN4 (A–D) or siCCN4 (E–H) for two days, and cultured inmicromasses.
(A, E) Two days after the transduction, mRNA expression levels of CCN4 gene were measured by real-time RT-PCR. (B, F) The cellular proteins were collected 24 h after chondrogenic in-
duction, and protein levels of SOX9were detected bywestern blot. β-ACTINwas used as protein loading control. (C, G) Twenty eight days after chondrogenic induction, histological anal-
ysis of hBMSC micromass cultures was performed for detection of glycosaminoglycans with safranin O staining, or collagen type II by immunohistochemistry. Graphs show the
quantitation of the positive area of collagen type II. (D, H) mRNA expression level of ACAN COL2 gene was measured by real time RT-PCR. The expression of each gene was normalized
to that of S29 ribosomal RNA. Bars represent the mean values and standard deviation (+/−SD) (n = 3). **p b 0.01, ***p b 0.001 (Student's t-tests). Results are representative data of
at least three independent experiments.
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on the TGF-β signaling pathway, we isolated chondrocytes from growth
plate of newborn WT and Ccn4-KO mice, and observed that TGF-β3-
induced phosphorylation of SMAD2/3 was also reduced in chondrocytes
derived from Ccn4-KOmice (Fig. 3C). These results explain in part the ef-
fect of CCN4 in enhancing TGF-β3-induced chondrogenic differentiation
of hBMSCs by promoting a stronger activation of SMAD2 and SMAD3.
3.4. Interaction between CCN4 and TGF-β3
It has been reported that CCN family members bind to themembers
of the TGF-β superfamily and regulate their function, thus we speculat-
ed that CCN4 could bind to TGF-β3. To test this hypothesis, hBMSCs
were transduced with adCCN4 and/or TGF-β3 overexpression vector
for 2 days and the protein levels of CCN4 or TGF-β3 were detected by
western blot (Fig. 4A and B). Immunoprecipitation (IP)–western blot
analysis showed a binding between DDK-tagged TGF-β3 and CCN4
(Fig. 4C). The direct binding between the two proteinswas also evaluat-
ed using recombinant proteins (rhCCN4 and rhTGF-β3); however, the
IP-western results did not conﬁrm that there was a direct binding be-
tween the two recombinant proteins (data not shown). Thus in cell ex-
tracts our data shows that CCN4 binds to TGF-β3, however we cannot
conclude deﬁnitively whether this binding is direct or, rather, requires
additional intermediating factors.
Since both CCN4 and TGF-β3 are secreted proteins, we then hypoth-
esized that they could interact to each other at the cell membrane orpericellularly at the extracellular level. Therefore, to determinewhether
CCN4 could regulate TGF-β3-to-cell binding afﬁnity, we performed an
on-cell protein binding assay with CCN4 overexpression and knock-
down conditions. First, we performed a quantitative analysis of the
amount of CCN4 bound to the surface of cells using anti-CCN4 antibody.
As shown in Fig. 4D and E, the amount of CCN4 on the surface of cells
was increased in the adCCN4-transduced hBMSCs; and on the other
hand, it was decreased in siCCN4-transduced hBMSCs.
Next, to perform the TGF-β3 afﬁnity assay, adCCN4 or siCCN4-
transduced hBMSCs were treated with rhTGF-β3 (1 μg/mL) for 4 h
and the amount of TGF-β3 bound to the cell membrane was detected
by using anti-TGF-β3 antibody. As predicted, increased amounts of
TGF-β3 were detected in hBMSCs transduced with adCCN4 (Fig. 4F).
Conversely, the binding afﬁnity of TGF-β3 to hBMSCs was decreased
under CCN4 knockdown condition (Fig. 4G). Taken together, these
data support the concept that CCN4 can enhance TGF-β3 function by fa-
cilitating its binding to the surface of hBMSCs and subsequently enhanc-
ing the activation of TGF-β downstream signaling.
3.5. Ccn4 deﬁciency decreases the chondrogenic differentiation related
markers in articular cartilage and delays articular cartilage regeneration
in vivo
Next, we isolated articular cartilage samples from the caput femur of
WT and Ccn4-KO mice (Fig. 5A–C), and found that the gene expression
levels of chondrocyte-related markers, Sox9, Acan and Col2a1, cartilage
Fig. 3. The effect of CCN4 onTGF-β3-SMADsignaling pathway in vitro. hBMSCswere transducedwith adCCN4 (A) or siCCN4 (B) for 2 days. (A, B) Transduced-hBMSCs inmonolayer culture
were treated with 10 ng/mL of TGF-β3 for 10min, and cellular proteins were collected for detection of SMAD2/3 activity. β-ACTINwas used as protein loading control. (C) Chondrocytes
were collected frommandibular condylar cartilage of newbornWT and Ccn4-KOmice, and stimulatedwith TGF-β3 for 10min. The cellular proteinswere collected for analysis of TGF-β3-
induced phosphorylation of SMAD2/3. SMAD2/3 activity was decreased in chondrocytes derived from Ccn4-KO mice, compared to WT mice.
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creased in Ccn4-KOmice (Figs. 5D, S2), indicating that CCN4 is necessary
for the maintenance of articular cartilage homeostasis. Of note, howev-
er, gene expression levels of collagen type X, alpha 1 (Col10a1), which is
hypertrophic chondrocytemarker and highly expressed in articular car-
tilage of OA, were not detected in articular cartilage of either WT or
Ccn4-KO mice (data not shown). Moreover, histological analysis of the
joints showed that there was no notable difference in morphology be-
tween WT and Ccn4-KO mice in the articular cartilage of the knees
(Fig. S3A–C).
Finally, we performed full-thickness articular cartilage defects in the
knee joints of WT and Ccn4-KO mice, and investigated whether CCN4
could work as a positive regulator of articular cartilage repair. One
month after the surgical defect, histological analysis of the joints re-
vealed the formation of a newly-formed cartilage-like tissue positively
stained with toluidine blue in WT mice (Fig. 6A). Moreover, immuno-
staining analysis showed that the newly-formed articular cartilage-
like tissue was positive for collagen type II (Fig. 6B). Conversely, no
cartilage-like tissue could be observed in the defect region of Ccn4-KO
(Fig. 6A), and a histopathology-based scoring of the repair cartilage
showed a signiﬁcant difference between the WT mice group and
Ccn4-KO mice group, indicating a substantial decrease in the ability of
the articular cartilage to repair in Ccn4-KO mice (Fig. 6C).4. Discussion
CCN family members are expressed in development of growth plate
cartilage and, because of their unique structural domain, they can inter-
act with various growth factors and ECM components [20]. CCN2 for ex-
ample, is expressed dominantly in the pre-hypertrophic zone of growth
plate and interacts with BMP-2 and ACAN, and regulates chondrocyte
proliferation and differentiation [4,21]. Furthermore, CCN2 was shown
to promote the regeneration of articular cartilage [22]; and aging-relat-
ed cartilage degradation could be prevented by cartilage-speciﬁc over-
expression of CCN2 [23]. Using the targeted mutation mice model of
CCN3, Roddy K.A. et al. have also reported that CCN3 is required for
maintenance of articular cartilage and for joint homeostasis [24].
CCN4 is also expressed in the hypertrophic zone [25], and our previ-
ous results show that CCN4 can regulate osteogenesis by controlling the
afﬁnity of BMP-2 to hBMSCs [8]. Despite the implications of our previ-
ous reports that elucidated the effect of CCN4 on osteoblast differentia-
tion and function [8,26], no study has yet determined a decisive role of
CCN4 in chondrogenesis and cartilage regeneration. In this study, we
demonstrated that CCN4 overexpression signiﬁcantly increased the
TGF-β3-induced chondrogenic differentiation of hBMSCs, and that
CCN4 plays important roles in joint homeostasis and in the process of
articular cartilage repair. Nevertheless, the articular cartilage defect
Fig. 4. Interaction between CCN4 and TGF-β3. hBMSCswere transducedwith adCCN4 and/or TGF-β3-DDK-over expression vector, and incubated for 2 days, before collection of cell lysates.
(A, B) Western blotting was performed using anti-CCN4 antibody or anti-DDK antibody, respectively. (C) Immunoprecipitation assay was performed using an anti-DDK antibody, and
CCN4 or TGF-β3/DDK was detected by immunoblotting using an anti-CCN4 or anti-DDK antibodies. (D, E) hBMSCs were transduced with adCCN4 or siCCN4, respectively. After two
days, cells were ﬁxed and, the amount of CCN4 bound to cells was measured by its immunoreactivity to anti-CCN4 antibody. (F, G) To analyze the interaction of CCN4 and TGF-β3,
ﬁxed cells were incubated with TGF-β3 for 2 h. The amount of TGF-β3 bound to cells was measured by its immunoreactivity using anti-DDK antibody. Bars represent the mean values
and standard deviation (+/−SD) (n = 3). **p b 0.01, ***p b 0.001 (Student's t-tests). Results are representative data of at least three independent experiments.
168 Y. Yoshioka et al. / Bone 83 (2016) 162–170model used in this study did not enable a complete repair of the articu-
lar surface in WT mice (Fig. 6). A possible reasoning for these results
could be the age of the mice, since Matsuoka et al. demonstrated thatFig. 5. Comparison of gene expression level of chondrogenic markers in articular cartilage betw
expression level of chondrogenicmarkers in healthy articular cartilage. Photograph and histolog
(A) and (B), respectively; and the histological image after isolation is shown in (C). (D) Total RNA
expression levels of chondrogenicmarkers weremeasured by real time RT-PCR. The expression
and standard deviation (+/−SD) (n = 3). *p b 0.05, **p b 0.01, ***p b 0.001 (Student's t-testsage is one of the crucial factors for the articular cartilage repair, with su-
perior results observed in young (3 week-old) or juvenile (4 week-old)
mice [17]; and thus, the 6 week-old mice used in this study could beeenWT and Ccn4-KOmice. Articular cartilage samples of caput femoris for analysis of gene
ical image of safranin O staining before the isolation of the articular cartilage are shown in
was collected from the articular cartilage separated from the caput femoris, and themRNA
of each genewas normalized to that of S29 ribosomal RNA. Bars represent themean values
). Results are representative data of at least three independent experiments.
Fig. 6. Comparison of the articular cartilage healing betweenWT and KOmice. The full-thickness articular cartilage defects of 400 μm in diameterwere surgically created in the knee joints
of WT and KO mice to evaluate the healing ability of articular cartilage. Four weeks after the surgery, samples were collected and specimens were stained with toluidine blue (A), and
immunostained for collagen type II (B). (C) Evaluation of the histological condition of the articular cartilage surface was performed using a modiﬁed ICRS score. Bars represent the
mean values and standard deviation (+/−SD) (n = 3). *p b 0.05 (Student's t-tests).
169Y. Yoshioka et al. / Bone 83 (2016) 162–170relatively aged, with a limited capacity for natural healing of the articu-
lar cartilage. Despite the incomplete repair of the articular cartilage in
WT mice, our results show that CCN4 may be playing important roles
in cartilage metabolism, as we could detect a signiﬁcant decrease in
the gene expression levels of Sox9, Acan, and Col2a1 in the articular car-
tilage of Ccn4-KO mice, which eventually, could also contribute to the
observed impaired healing capacity of chondrocytes.
Additionally, our recent article showed that the body length of Ccn4-
KOmice is slightly but signiﬁcantly reduced compared towild typemice
[16]. We also analyzed the growth plates of growingmice at embryonic
day E18.5 and showed that the hypertrophic zone of growth plate was
expanded in the Ccn4-KO compared to wild type mice. From these
data, we also suspect that CCN4 could regulate the long bone growth
by controlling the apoptosis of hypertrophic chondrocytes. Further ex-
periments will be required to elucidate this issue.
Of note, in vitro experiments showed that CCN4 alone does not have
any function for osteo-chondrogenesis. Therefore, CCN4 action may be
mediated by interacting with other growth factors associated with
chondrogenesis, and regulating their function. Here we show that
CCN4 can interact with and control TGF-β3 function; however, addi-
tional experiments are necessary to clarify the exact mechanisms of ac-
tion, since the direct binding between the two factors could not be
determined. Other cellular mechanisms, independent of TGF-β3, could
also be involved in the CCN4's role in chondrogenesis. For instance, it
has been reported that tumor necrosis factor-α (TNF-α), a pro-
inﬂammatory cytokine, induces focal loss of cartilage in OA knee joints
[27]. Additionally, in the cardiac ﬁbroblast, TNF-α up-regulates the ex-
pression level of CCN4 via its cyclic AMP response element-binding pro-
tein (CREB) site, and that CCN4 protects from TNF-α induced cell death
[28]. Indeed, elevated levels of both TNF-α andCCN4have been found in
the cartilage of OA patients [9,10,29,30] and, CCN4 could be not only a
key component in the process of cartilage differentiation but also
could be playing important roles in organizing the inﬂammatory condi-
tion in OA, and promoting cartilage repair.
In summary, for the ﬁrst time, we showed that CCN4 exerts a posi-
tive effect on TGF-β3-induced chondrogenesis by modulating TGF-β3
binding to the surface of hBMSCs and enhancing its downstream signal-
ing. Further investigations are necessary for a better understanding of
the underlying molecular and cellular mechanisms involved in effect
of CCN family proteins in the process of chondrogenesis and/or cartilage
repair, aswell as for advancing new therapeutic modalities for OA to in-
crease current clinical outcomes.Conﬂict of interest
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